{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T10:58:37Z","timestamp":1763809117730},"reference-count":57,"publisher":"Societas Neurologica Japonica","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5692\/clinicalneurol.52.303","type":"journal-article","created":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T05:01:15Z","timestamp":1338267675000},"page":"303-313","source":"Crossref","is-referenced-by-count":7,"title":["Diagnosis, pathomechanism and treatment of CADASIL"],"prefix":"10.5692","volume":"52","author":[{"given":"Toshiki","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0393-256"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/383707a0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Desmond DW, Moroney JT, Lynch T, et al. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999;30:1230-1233.","DOI":"10.1161\/01.STR.30.6.1230"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004;127:2533-2539.","DOI":"10.1093\/brain\/awh282"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Peters N, Herzog J, Opherk C, et al. A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke 2004;35:1603-1608.","DOI":"10.1161\/01.STR.0000131546.71733.f1"},{"key":"6","unstructured":"7) Gunda B, Chabriat H, Bereczki D. Cadasil and other hereditary small vessel diseases of the brain -increasingly diagnosed conditions underlying familial ischaemic stroke and dementia. Ideggyogy Sz 2011;64:88-100."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2<145::AID-ANA3>3.0.CO;2-P"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2<sup>*<\/sup>-weighted gradient-echo MRI. Brain 2004;127:2265-2275.","DOI":"10.1093\/brain\/awh253"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1161\/hs0102.100885"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Viswanathan A, Gschwendtner A, Guichard JP, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology 2007;69:172-179.","DOI":"10.1212\/01.wnl.0000265221.05610.70"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Ragoschke-Schumm A, Axer H, Fitzek C, et al. Intracerebral haemorrhage in CADASIL. J Neurol Neurosurg Psychiatry 2005;76:1606-1607.","DOI":"10.1136\/jnnp.2004.059212"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14) Duering M, Zieren N, Herve D, et al. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain 2011;134:2366-2375.","DOI":"10.1093\/brain\/awr169"},{"key":"13","doi-asserted-by":"crossref","unstructured":"16) Jouvent E, Poupon C, Gray F, et al. Intracortical infarcts in small vessel disease: a combined 7-T postmortem MRI and neuropathological case study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2011;42:e27-e30.","DOI":"10.1161\/STROKEAHA.110.594218"},{"key":"14","doi-asserted-by":"crossref","unstructured":"17) Kochunov P, Mangin JF, Coyle T, et al. Age-related morphology trends of cortical sulci. Hum Brain Mapp 2005;26:210-220.","DOI":"10.1002\/hbm.20198"},{"key":"15","doi-asserted-by":"crossref","unstructured":"18) Swartz RH, Stuss DT, Gao F, et al. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke 2008;39:822-830.","DOI":"10.1161\/STROKEAHA.107.491936"},{"key":"16","doi-asserted-by":"crossref","unstructured":"20) Jouvent E, Mangin JF, Duchesnay E, et al. Longitudinal changes of cortical morphology in CADASIL. Neurobiol Aging 2012;33:1002e29-1002e36.","DOI":"10.1016\/j.neurobiolaging.2011.09.013"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.1998.530219.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"22) Joutel A, Dodick DD, Parisi JE, et al. De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol 2000;47:388-391.","DOI":"10.1002\/1531-8249(200003)47:3<388::AID-ANA19>3.0.CO;2-Q"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)08083-5"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000216259.99811.50"},{"key":"21","doi-asserted-by":"crossref","unstructured":"26) Mazzei R, Conforti FL, Lanza PL, et al. A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL. Neurology 2004;63:561-564.","DOI":"10.1212\/01.WNL.0000133399.37716.84"},{"key":"22","doi-asserted-by":"crossref","unstructured":"27) Quattrone A, Mazzei R. Cysteine-sparing notch3 mutations: cadasil or cadasil variants? Neurology 2009; 72: 2135-2136; author reply 2136.","DOI":"10.1212\/01.wnl.0000349699.12456.06"},{"key":"23","doi-asserted-by":"crossref","unstructured":"28) Dichgans M, Filippi M, Bruning R, et al. Quantitative MRI in CADASIL: Correlation with disability and cognitive performance. Neurology 1999;52:1361.","DOI":"10.1212\/WNL.52.7.1361"},{"key":"24","doi-asserted-by":"crossref","unstructured":"29) Lesnik Oberstein SA, van den Boom R, van Buchem MA, et al. Cerebral microbleeds in CADASIL. Neurology 2001;57:1066-1070.","DOI":"10.1212\/WNL.57.6.1066"},{"key":"25","doi-asserted-by":"crossref","unstructured":"30) Monet-Lepretre M, Bardot B, Lemaire B, et al. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain 2009;132:1601-1612.","DOI":"10.1093\/brain\/awp049"},{"key":"26","unstructured":"31) Matsumoto H, Tsumoto M, Yamamoto T, et al. A case of early stage CADASIL showing only dizziness and vertigo with a novel mutation of Notch 3 gene. Rinsho Shinkeigaku 2005;45:27-31."},{"key":"27"},{"key":"28","doi-asserted-by":"crossref","unstructured":"33) Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776.","DOI":"10.1126\/science.284.5415.770"},{"key":"29","doi-asserted-by":"crossref","unstructured":"35) Joutel A, Monet M, Domenga V, et al. Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP\/JK signaling Pathway. Am J Hum Genet 2004;74:338-347.","DOI":"10.1086\/381506"},{"key":"30","doi-asserted-by":"crossref","unstructured":"38) Haritunians T, Chow T, De Lange RP, et al. Functional analysis of a recurrent missense mutation in Notch3 in CADASIL. J Neurol Neurosurg Psychiatry 2005;76:1242-1248.","DOI":"10.1136\/jnnp.2004.051854"},{"key":"31","doi-asserted-by":"crossref","unstructured":"39) Low WC, Santa Y, Takahashi K, et al. CADASIL-causing mutations do not alter Notch3 receptor processing and activation. Neuroreport 2006;17:945-949.","DOI":"10.1097\/01.wnr.0000223394.66951.48"},{"key":"32","doi-asserted-by":"crossref","unstructured":"40) Takahashi K, Adachi K, Yoshizaki K, et al. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum Mol Genet 2010;19:79-89.","DOI":"10.1093\/hmg\/ddp468"},{"key":"33","doi-asserted-by":"crossref","unstructured":"41) Watanabe-Hosomi A, Watanabe Y, Tanaka M, et al. Transendocytosis is impaired in CADASIL-mutant NOTCH3. Exp Neurol 2011;233:303-311.","DOI":"10.1016\/j.expneurol.2011.10.020"},{"key":"34","doi-asserted-by":"crossref","unstructured":"44) Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology 2002;59:1134-1138.","DOI":"10.1212\/WNL.59.8.1134"},{"key":"35","doi-asserted-by":"crossref","unstructured":"45) Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 2009;132:933-939.","DOI":"10.1093\/brain\/awn364"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)07142-2"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0116-2"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000032620.91848.1C"},{"key":"39","doi-asserted-by":"crossref","unstructured":"50) Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51:452-457.","DOI":"10.1212\/WNL.51.2.452"},{"key":"40","unstructured":"51) Tomimoto H, Ohtani R, Wakita H, et al. Distribution of ischemic leukoaraiosis in MRI: a difference from white matter lesions in CADASIL. No To Shinkei 2005;57:125-130."},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.528299"},{"key":"42","doi-asserted-by":"crossref","unstructured":"53) Krebs LT, Xue Y, Norton CR, et al. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 2003;37:139-143.","DOI":"10.1002\/gene.10241"},{"key":"43","doi-asserted-by":"crossref","unstructured":"56) Lundkvist J, Zhu S, Hansson EM, et al. Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis 2005;41:13-22.","DOI":"10.1002\/gene.20091"},{"key":"44","doi-asserted-by":"crossref","unstructured":"57) Ruchoux MM, Domenga V, Brulin P, et al. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol 2003;162:329-342.","DOI":"10.1016\/S0002-9440(10)63824-2"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39733"},{"key":"46","doi-asserted-by":"crossref","unstructured":"59) Chabriat H, Pappata S, Ostergaard L, et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000;31:1904-1912.","DOI":"10.1161\/01.STR.31.8.1904"},{"key":"47","doi-asserted-by":"crossref","unstructured":"61) Singhal S, Markus HS. Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). J Neurol 2005;252:163-167.","DOI":"10.1007\/s00415-005-0624-3"},{"key":"48","doi-asserted-by":"crossref","unstructured":"62) Dubroca C, Lacombe P, Domenga V, et al. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke 2005;36:113-117.","DOI":"10.1161\/01.STR.0000149949.92854.45"},{"key":"49","doi-asserted-by":"crossref","unstructured":"63) Liem MK, Lesnik Oberstein SA, Haan J, et al. Cerebrovascular reactivity is a main determinant of white matter hyperintensity progression in CADASIL. AJNR Am J Neuroradiol 2009;30:1244-1247.","DOI":"10.3174\/ajnr.A1533"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1007\/BF00571504"},{"key":"51","doi-asserted-by":"crossref","unstructured":"65) Stenborg A, Kalimo H, Viitanen M, et al. Impaired endothelial function of forearm resistance arteries in CADASIL patients. Stroke 2007;38:2692-2697.","DOI":"10.1161\/STROKEAHA.107.490029"},{"key":"52","doi-asserted-by":"crossref","unstructured":"66) Gobron C, Vahedi K, Vicaut E, et al. Characteristic features of in vivo skin microvascular reactivity in CADASIL. J Cereb Blood Flow Metab 2007;27:250-257.","DOI":"10.1038\/sj.jcbfm.9600356"},{"key":"53","doi-asserted-by":"crossref","unstructured":"67) Ding XQ, Hagel C, Ringelstein EB, et al. MRI features of pontine autosomal dominant microangiopathy and leukoencephalopathy (PADMAL). J Neuroimaging 2010;20:134-140.","DOI":"10.1111\/j.1552-6569.2008.00336.x"},{"key":"54","doi-asserted-by":"crossref","unstructured":"68) Fujiwara Y, Mizuno T, Okuyama C, et al. Simultaneous Impairment of Intracranial and Peripheral Artery Vasoreactivity in CADASIL Patients. Cerebrovasc Dis 2011;33:128-134.","DOI":"10.1159\/000334185"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e31816c82a6"},{"key":"56"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70046-2"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["CADASIL\u306e\u8a3a\u65ad\uff0c\u75c5\u614b\uff0c\u6cbb\u7642\u306e\u9032\u6b69\u2015\u672c\u90a6\u306b\u304a\u3051\u308bCADASIL\u8a3a\u65ad\u57fa\u6e96\u306e\u4f5c\u6210\u2015"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:04:40Z","timestamp":1621541080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/52\/5\/52_303\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.52.303","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}